Ponatinib
Records for this ingredient, by country (identity only).
ATC L01EA05 · 11 markets · 32 records
AU 7 records · 6 shown of 6
- 15 mgtabletIclusig
- 45 mgtabletIclusig
- 48.1 mgtabletICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle
- 32.05 mgtabletICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle
- 16 mgtabletICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle
- 10.68 mgtabletICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 6 records · 3 shown of 3
US 4 records · 4 shown of 4
FR 3 records · 3 shown of 3
- 15 mgtabletICLUSIG 15 mg, comprimé pelliculé
- 45 mgtabletICLUSIG 15 mg, comprimé pelliculé
- 30 mgtabletICLUSIG 15 mg, comprimé pelliculé
HK 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CA 1 records · 1 shown of 1
- 15 mgtabletIclusig
CN 1 records · 1 shown of 1
- 15 mgtablet英可欣泊那替尼
JP 1 records · 1 shown of 1
- 15 mgtabletアイクルシグ錠15mg
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | HK | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 mg tablet | Iclusig | Manufacturer: Incyte Biosciences UK Ltd ×3 Iclusig | Iclusig | Iclusig | Iclusig | 英可欣泊那替尼 | Iclusig | アイクルシグ錠15mg | ICLUSIG 15 mg, comprimé pelliculé | ||
| 45 mg tablet | Iclusig | Manufacturer: Incyte Biosciences UK Ltd ×3 Iclusig | Iclusig | Iclusig | Iclusig | ICLUSIG 15 mg, comprimé pelliculé | |||||
| 30 mg tablet | Iclusig | Manufacturer: Incyte Biosciences UK Ltd ×3 Iclusig | Iclusig | ICLUSIG 15 mg, comprimé pelliculé | |||||||
| 48.1 mg tablet | ICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle | ||||||||||
| 32.05 mg tablet | ICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle | ||||||||||
| 16 mg tablet | ICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle | ||||||||||
| 10.68 mg tablet | ICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle | ||||||||||
| 10 mg tablet | Iclusig | ||||||||||
unknown | Iclusig | Iclusig | Iclusig |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.